--- title: "TRINITY BIOTECH (TRIB) stock: news and investor profile" url: "https://aibio.space/companies/trinity-biotech/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TRINITY BIOTECH PLC (NASDAQ: TRIB), United States. Listing facts, related biotech companies and news on aibio.space." --- TRIB TRINITY BIOTECH PLC NASDAQ · United States # TRINITY BIOTECH (TRIB) news Debt Financing · 2026-08-14 ## [Trinity Biotech amends Perceptive term loan, adding about $2.5 million](https://aibio.space/news/trinity-biotech-amends-perceptive-term-loan-adding-about-2-5-million/) The amendment provides approximately $2.5 million of new debt funding and approximately $4.5 million of capitalized interest, for a total investment of approximately $7.0 million. ## Latest TRINITY BIOTECH news We have not published a story on TRINITY BIOTECH yet. When there is news, it will appear here. ## TRINITY BIOTECH at a glance - **Ticker**: TRIB - **Listing**: NASDAQ - **Country**: United States - **Cash, Dec 31, 2024**: $5.2 million ### Related companies - [Autonomix Medical](https://aibio.space/companies/autonomix-medical/) NASDAQ: AMIX - [BIO-TECHNE](https://aibio.space/companies/bio-techne/) NASDAQ: TECH - [Rocket One](https://aibio.space/companies/rocket-one/) NASDAQ: RKTO - [COOPER COMPANIES, INC.](https://aibio.space/companies/cooper-companies/) NASDAQ: COO - [MDxHealth SA](https://aibio.space/companies/mdxhealth/) NASDAQ: MDXH - [Guardant Health](https://aibio.space/companies/guardant-health/) NASDAQ: GH - [FOXO TECHNOLOGIES INC.](https://aibio.space/companies/foxo-technologies/) OTC: FOXO - [Sangamo Therapeutics](https://aibio.space/companies/sangamo-therapeutics/) OTC: SGMOQ ### Also on NASDAQ - [Precigen](https://aibio.space/companies/precigen/) PGEN - [BioMarin Pharmaceutical](https://aibio.space/companies/biomarin-pharmaceutical/) BMRN - [ARS Pharmaceuticals](https://aibio.space/companies/ars-pharmaceuticals/) SPRY - [Clene](https://aibio.space/companies/clene/) CLNN - [Kiora Pharmaceuticals](https://aibio.space/companies/kiora-pharmaceuticals/) KPRX - [Moderna](https://aibio.space/companies/moderna/) MRNA ## What TRINITY BIOTECH does Trinity Biotech plc is a biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors. Its ADSs trade on the Nasdaq Global Market under the symbol TRIB, and its principal offices are in Bray, County Wicklow, Ireland. Following its acquisition of the biosensor assets of Waveform Technologies Inc. in 2024, it is developing biosensor devices, beginning with a continuous glucose monitoring (CGM) product. Through its subsidiaries it develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments. Its products detect autoimmune, infectious and sexually transmitted diseases, disorders of the liver and intestine, and markers for diabetes. Its principal point-of-care product is Uni-Gold HIV, used for many years in sub-Saharan Africa, and its TrinScreen HIV rapid screening test received World Health Organisation approval in February 2022. Its Premier Hb9210 HbA1c analyser is CE marked and FDA cleared, and in February 2026 it became the only HbA1c analyser worldwide to receive the IFCC Gold Classification for 2026. The company sells through its own sales organisations and through distributors into approximately 100 countries. | Product or program | What it is | Stage | |---|---|---| | Uni-Gold HIV | Principal point-of-care HIV test, used as a confirmatory test in Africa | | | TrinScreen | HIV point-of-care rapid screening test | WHO approved; commercial shipments since 2023 | | Premier Hb9210 | HbA1c analyser for monitoring diabetes and identifying pre-diabetes | CE marked and FDA cleared | | CGM device | Continuous glucose monitoring biosensor from Waveform assets | in development | Summarised from the company's [20-F filed Apr 30, 2026](https://www.sec.gov/Archives/edgar/data/888721/000155485526000848/trib-20251231.htm). ## TRINITY BIOTECH annual financials | Line | FY2024 | FY2023 | |---|---|---| | Revenue | [$61.6 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | [$56.8 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | | Research and development | [$4.5 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | [$4.4 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | | Net income (loss) | [-$31.2 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | [-$36.9 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | | Cash from operations | [-$4.2 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | [-$11.6 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | | Cash and equivalents | [$5.2 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | [$3.7 million](https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/) | Latest balance sheet, Dec 31, 2024 (20-F): cash and equivalents $5.2 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about TRINITY BIOTECH What is the ticker symbol of TRINITY BIOTECH? TRINITY BIOTECH PLC trades under the ticker TRIB on NASDAQ. Where is TRINITY BIOTECH listed? TRINITY BIOTECH PLC is listed on NASDAQ. Which country or territory is TRINITY BIOTECH listed under? Our directory records TRINITY BIOTECH PLC under United States. Does aibio.space cover TRINITY BIOTECH? aibio.space lists TRINITY BIOTECH PLC among 2,820 public biotech companies and publishes its news here as stories appear. What does TRINITY BIOTECH develop? Trinity Biotech plc is a biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors. Its ADSs trade on the Nasdaq Global Market under the symbol TRIB, and its principal offices are in Bray, County Wicklow, Ireland. What is Uni-Gold HIV from TRINITY BIOTECH? Uni-Gold HIV: Principal point-of-care HIV test, used as a confirmatory test in Africa What is TrinScreen from TRINITY BIOTECH? TrinScreen: HIV point-of-care rapid screening test Stage: WHO approved; commercial shipments since 2023. What was TRINITY BIOTECH's revenue last year? $61.6 million for the fiscal year ended Dec 31, 2024, as reported to the SEC. Is TRINITY BIOTECH profitable? TRINITY BIOTECH PLC reported a net loss of $31.2 million for the fiscal year ended Dec 31, 2024, and used $4.2 million of cash in operations, per its annual report to the SEC. How much does TRINITY BIOTECH spend on research and development? $4.5 million in the fiscal year ended Dec 31, 2024, per its annual report. How much cash does TRINITY BIOTECH have? $5.2 million in cash at Dec 31, 2024, per its 20-F. What is the latest TRINITY BIOTECH (TRIB) stock news? Our latest story on TRINITY BIOTECH, dated Aug 14, 2026: "Trinity Biotech amends Perceptive term loan, adding about $2.5 million". The amendment provides approximately $2.5 million of new debt funding and approximately $4.5 million of capitalized interest, for a total investment of approximately $7.0 million. [Source](https://aibio.space/news/trinity-biotech-amends-perceptive-term-loan-adding-about-2-5-million/). Does TRINITY BIOTECH have debt, a term loan or convertible notes? Our latest debt story, dated Aug 14, 2026: "Trinity Biotech amends Perceptive term loan, adding about $2.5 million". The amendment provides approximately $2.5 million of new debt funding and approximately $4.5 million of capitalized interest, for a total investment of approximately $7.0 million. [Source](https://aibio.space/news/trinity-biotech-amends-perceptive-term-loan-adding-about-2-5-million/). How can I follow TRINITY BIOTECH (TRIB) news? Press Follow on this page to add TRINITY BIOTECH to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming TRINITY BIOTECH so far, in Debt Financing. ## Investor discussion: TRINITY BIOTECH Members talk about TRINITY BIOTECH (TRIB). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at TRINITY BIOTECH, newest first. Each line links the filing it comes from. 1. 2026-08-28 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/888721/000155485526001933/ex991_1.htm) 2. 2026-07-22 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/888721/000155485526001607/ex991_1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:TRIB on TradingView](https://www.tradingview.com/symbols/NASDAQ-TRIB/). ## Listing details TRINITY BIOTECH PLC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TRIB, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: TRINITY BIOTECH PLC - **Ticker**: TRIB - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/trinity-biotech/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "TRINITY BIOTECH (TRIB) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/trinity-biotech/